Single and Multiple Ascending Dose Study of AER-01

PHASE1UnknownINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

May 26, 2023

Primary Completion Date

August 31, 2024

Study Completion Date

August 31, 2024

Conditions
COPD
Interventions
DRUG

AER-01

AER-01 solution for inhalation delivered via nebulizer

DRUG

Placebo

Placebo for solution for inhalation delivered via nebulizer

Trial Locations (2)

Unknown

RECRUITING

CMAX, Adelaide

RECRUITING

Scientia Clinical Research, Sydney

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Aer Therapeutics

INDUSTRY